Project Number EUJPND-Mason-Drew-271 Agency/Funding Organization The Mason Foundation Funding Year 2016 View Full Project Details for Targeting mitochondrial dysfunction as a potential therapy for the prevention of neurodegenerative disorders including Alzheimer's Disease (AD) Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 2. Identification and Validation of Novel Targets Researcher and Organization Principal Investigator Drew, Brian Principal Investigator First Name Brian Principal Investigator Last Name Drew Awardee Organization BakerIDI Heart & Diabetes Institute Contact PI Country Australia Project Detail FY Overall Cost $38,229 Funding Organization Agency/Funding Organization The Mason Foundation Funding Organization Country Australia Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
